352 related articles for article (PubMed ID: 27053685)
21. Antagonistic cannabinoid CB1/dopamine D2 receptor interactions in striatal CB1/D2 heteromers. A combined neurochemical and behavioral analysis.
Marcellino D; Carriba P; Filip M; Borgkvist A; Frankowska M; Bellido I; Tanganelli S; Müller CE; Fisone G; Lluis C; Agnati LF; Franco R; Fuxe K
Neuropharmacology; 2008 Apr; 54(5):815-23. PubMed ID: 18262573
[TBL] [Abstract][Full Text] [Related]
22. Distinct roles of dopamine D2L and D2S receptor isoforms in the regulation of protein phosphorylation at presynaptic and postsynaptic sites.
Lindgren N; Usiello A; Goiny M; Haycock J; Erbs E; Greengard P; Hokfelt T; Borrelli E; Fisone G
Proc Natl Acad Sci U S A; 2003 Apr; 100(7):4305-9. PubMed ID: 12651945
[TBL] [Abstract][Full Text] [Related]
23. Allosteric modulator ORG27569 induces CB1 cannabinoid receptor high affinity agonist binding state, receptor internalization, and Gi protein-independent ERK1/2 kinase activation.
Ahn KH; Mahmoud MM; Kendall DA
J Biol Chem; 2012 Apr; 287(15):12070-82. PubMed ID: 22343625
[TBL] [Abstract][Full Text] [Related]
24. Opposite function of dopamine D1 and N-methyl-D-aspartate receptors in striatal cannabinoid-mediated signaling.
Daigle TL; Wetsel WC; Caron MG
Eur J Neurosci; 2011 Nov; 34(9):1378-89. PubMed ID: 22034973
[TBL] [Abstract][Full Text] [Related]
25. Role of adrenoceptors in the regulation of dopamine/DARPP-32 signaling in neostriatal neurons.
Hara M; Fukui R; Hieda E; Kuroiwa M; Bateup HS; Kano T; Greengard P; Nishi A
J Neurochem; 2010 May; 113(4):1046-59. PubMed ID: 20236221
[TBL] [Abstract][Full Text] [Related]
26. Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptor.
Glass M; Felder CC
J Neurosci; 1997 Jul; 17(14):5327-33. PubMed ID: 9204917
[TBL] [Abstract][Full Text] [Related]
27. RGS2 modulates the activity and internalization of dopamine D2 receptors in neuroblastoma N2A cells.
Luessen DJ; Hinshaw TP; Sun H; Howlett AC; Marrs G; McCool BA; Chen R
Neuropharmacology; 2016 Nov; 110(Pt A):297-307. PubMed ID: 27528587
[TBL] [Abstract][Full Text] [Related]
28. Distinct regulation of internalization and mitogen-activated protein kinase activation by two isoforms of the dopamine D2 receptor.
Kim SJ; Kim MY; Lee EJ; Ahn YS; Baik JH
Mol Endocrinol; 2004 Mar; 18(3):640-52. PubMed ID: 14684845
[TBL] [Abstract][Full Text] [Related]
29. Addicting drugs utilize a synergistic molecular mechanism in common requiring adenosine and Gi-beta gamma dimers.
Yao L; Fan P; Jiang Z; Mailliard WS; Gordon AS; Diamond I
Proc Natl Acad Sci U S A; 2003 Nov; 100(24):14379-84. PubMed ID: 14605213
[TBL] [Abstract][Full Text] [Related]
30. CB1 cannabinoid receptor-mediated increases in cyclic AMP accumulation are correlated with reduced Gi/o function.
Eldeeb K; Leone-Kabler S; Howlett AC
J Basic Clin Physiol Pharmacol; 2016 May; 27(3):311-22. PubMed ID: 27089415
[TBL] [Abstract][Full Text] [Related]
31. Mitochondrial CB1 receptor is involved in ACEA-induced protective effects on neurons and mitochondrial functions.
Ma L; Jia J; Niu W; Jiang T; Zhai Q; Yang L; Bai F; Wang Q; Xiong L
Sci Rep; 2015 Jul; 5():12440. PubMed ID: 26215450
[TBL] [Abstract][Full Text] [Related]
32. Dopamine modulation of excitatory currents in the striatum is dictated by the expression of D1 or D2 receptors and modified by endocannabinoids.
André VM; Cepeda C; Cummings DM; Jocoy EL; Fisher YE; William Yang X; Levine MS
Eur J Neurosci; 2010 Jan; 31(1):14-28. PubMed ID: 20092552
[TBL] [Abstract][Full Text] [Related]
33. Gα
Finlay DB; Cawston EE; Grimsey NL; Hunter MR; Korde A; Vemuri VK; Makriyannis A; Glass M
Br J Pharmacol; 2017 Aug; 174(15):2545-2562. PubMed ID: 28516479
[TBL] [Abstract][Full Text] [Related]
34. The Gαi protein subclass selectivity to the dopamine D
Polit A; Rysiewicz B; Mystek P; Błasiak E; Dziedzicka-Wasylewska M
Cell Commun Signal; 2020 Dec; 18(1):189. PubMed ID: 33308256
[TBL] [Abstract][Full Text] [Related]
35. On the existence of a possible A2A-D2-β-Arrestin2 complex: A2A agonist modulation of D2 agonist-induced β-arrestin2 recruitment.
Borroto-Escuela DO; Romero-Fernandez W; Tarakanov AO; Ciruela F; Agnati LF; Fuxe K
J Mol Biol; 2011 Mar; 406(5):687-99. PubMed ID: 21256133
[TBL] [Abstract][Full Text] [Related]
36. Characterization of anandamide-stimulated cannabinoid receptor signaling in human ULTR myometrial smooth muscle cells.
Brighton PJ; McDonald J; Taylor AH; Challiss RA; Lambert DG; Konje JC; Willets JM
Mol Endocrinol; 2009 Sep; 23(9):1415-27. PubMed ID: 19477951
[TBL] [Abstract][Full Text] [Related]
37. Co-expression of the human cannabinoid receptor coding region splice variants (hCB₁) affects the function of hCB₁ receptor complexes.
Bagher AM; Laprairie RB; Kelly ME; Denovan-Wright EM
Eur J Pharmacol; 2013 Dec; 721(1-3):341-54. PubMed ID: 24091169
[TBL] [Abstract][Full Text] [Related]
38. Differential signaling of dopamine-D2S and -D2L receptors to inhibit ERK1/2 phosphorylation.
Van-Ham II; Banihashemi B; Wilson AM; Jacobsen KX; Czesak M; Albert PR
J Neurochem; 2007 Sep; 102(6):1796-1804. PubMed ID: 17767702
[TBL] [Abstract][Full Text] [Related]
39. Dopamine D2 long receptor-deficient mice display alterations in striatum-dependent functions.
Wang Y; Xu R; Sasaoka T; Tonegawa S; Kung MP; Sankoorikal EB
J Neurosci; 2000 Nov; 20(22):8305-14. PubMed ID: 11069937
[TBL] [Abstract][Full Text] [Related]
40. Cannabinoid-induced depression of synaptic transmission is switched to stimulation when dopaminergic tone is increased in the globus pallidus of the rodent.
Caballero-Florán RN; Conde-Rojas I; Oviedo Chávez A; Cortes-Calleja H; Lopez-Santiago LF; Isom LL; Aceves J; Erlij D; Florán B
Neuropharmacology; 2016 Nov; 110(Pt A):407-418. PubMed ID: 27506997
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
